Methods for treatment of asthma using S-oxybutynin
US6294582A · kind A · utility
13Cited by
4References
16Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | May 17, 2000 |
| Grant date | Sep 25, 2001 |
| Priority date | — |
| Expiry date | May 17, 2020 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P11/06
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Substantially optically pure S-oxybutynin, or a pharmaceutically acceptable salt thereof, is administered as a treatment for asthma. Such treatment is provided while reducing the adverse effects associated with the administration of racemic oxybutynin.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.